LDOS — Leidos Holdings, Inc.

Summary of Leidos (LDOS) Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 Revenue: $4.2 billion, down 3.6% year-over-year, but adjusted for a 6-week government shutdown and an extra week in Q4 2024, revenue would have increased approximately 4%.
• Full Year Revenue: $17.2 billion, up 3.1%.
• Adjusted EBITDA Margin: 14.1% for the year, with Q4 margin at 13.2%, reflecting a year-over-year increase of 120 and 160 basis points, respectively.
• Non-GAAP Diluted EPS: $2.76 for Q4 and $11.99 for the year, representing a 17% increase year-over-year.
• Free Cash Flow: $452 million in Q4 and $1.63 billion for the year, with a conversion rate of 104%.
• Net Bookings: $5.6 billion in Q4, maintaining a book-to-bill ratio of 1.3x.

2. Strategic Updates and Business Highlights

• Strategic Focus: Leidos is executing its NorthStar 2030 strategy, emphasizing innovation and alignment with U.S. government priorities.
• Key Contracts: Notable awards include a $2.2 billion contract for passive radar systems and a $455 million contract for Air Force Cloud services.
• Acquisitions: The acquisition of Kudu Dynamics has enhanced cyber capabilities, while the planned acquisition of ENTRUST Solutions Group for $2.4 billion aims to strengthen the energy engineering segment.
• Investment in Growth: Increased capital expenditures to $350 million in 2026, focusing on production capacity and technology development.

3. Forward Guidance and Outlook

• 2026 Revenue Guidance: Expected between $17.5 billion and $17.9 billion, reflecting growth of up to 4% over 2025.
• Adjusted EBITDA Margin: Projected to be in the mid-13% range.
• Non-GAAP Diluted EPS Guidance: Anticipated between $12.05 and $12.45.
• Operating Cash Flow: Expected to remain robust at $1.75 billion, despite a $90 million headwind from Section 174 timing.

4. Bad News, Challenges, or Points of Concern

• Q4 Revenue Decline: The reported revenue decrease of 3.6% reflects challenges from the government shutdown and calendar effects.
• Market Pressures: Concerns about the impact of AI on pricing and competition in digital modernization programs.
• Transition Risks: Potential challenges in the Health segment due to the transition of the DHMSM program and the entry of a fourth vendor in the VA medical exam recompete.

5. Notable Q&A Insights

• Investment Areas: Management indicated a focus on co-investment opportunities with the Department of Defense and other agencies, emphasizing a broad investment strategy across growth pillars.
• Segment Performance: Expected slower growth in the first half of 2026, with acceleration anticipated in the latter half, driven by new program wins and a robust business development pipeline.
• Recompete Strategy: Management expressed confidence in maintaining profitability in the Health segment despite competitive pressures, focusing on efficiency and effectiveness in veteran services.
• Capital Allocation: No specific buyback plans were included in the guidance, as capital will be prioritized for the ENTRUST acquisition and growth investments.

Overall, Leidos reported a solid performance in 2025, navigating external challenges while positioning itself for growth through strategic investments and acquisitions. The outlook for 2026 remains positive, with expectations for revenue growth and margin stability, although there are notable risks and competitive pressures to monitor.